通过改变其聚合结构来调节以酸触发的二元性产药为基础的药物自我递送系统的药物释放性能
1State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China.
Molecules (Basel, Switzerland)
|August 10, 2024
概括
多克索鲁比 (DOX) 的新二维预制药提供无载体药物自递送系统 (DSDS). 酸触发释放和控制的纳米医学结构通过调节药物释放率来提高抗瘤疗效.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 在瘤学瘤学.
背景情况:
- 二元前药物被探索为无载体药物自递送系统 (DSDSs).
- 刺激反应药物释放通常由药物分子结合和链接器灵敏度来控制.
- 控制药物释放动力学对于有效的抗瘤治疗至关重要.
研究的目的:
- 通过使用一种酸性连剂,合成一种由酸触发的多克索鲁比辛 (DOX) 二次性前药物.
- 为了研究二元前药物的药物负载能力和体内稳定性.
- 探索不同制造方法对纳米医药聚合结构和药物释放概况的影响.
主要方法:
- 通过通过一种酸性基连接剂将两个DOX分子结合在一起,合成一个二元前药物.
- 使用快速沉和缓慢自组装等方法制造纳米药物.
- 在模拟血液循环中评估药物泄漏和纳米药物释放性能.
主要成果:
- 合成的二元原药呈现出高剂量药物含量,相当于纯DOX.
- 在模拟血液循环期间观察到有效抑制过早的药物泄漏.
- 不同的制造方法导致了不同的聚合结构,影响了药物释放率.
结论:
- 酸触发的DOX二元原药可以作为有效的无载体药物自递送系统 (DSDS).
- 控制纳米药物制造是一种可行的策略,用于调整药物释放动力学,以提高治疗结果.
- 这种方法有望通过优化药物输送超出单独的分子设计来提高抗瘤疗效.
相关概念视频
Factors Affecting Dissolution: Particle Size and Effective Surface Area
774
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
774
Factors Influencing Drug Absorption: Pharmaceutical Parameters
124
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
124
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
190
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
190
Factors Influencing Drug Absorption: Physicochemical Parameters
247
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
247
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
293
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
293
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K


